Search Within

Heather Lynn Mcarthur

Formats
  1. Journal Article (41)
  2. Meeting Abstract (40)
  3. Book Section (1)
Groups
  1. Breast Medicine Service (67)
  2. Department of Medicine (67)
  3. Solid Tumor Oncology Division (67)
  4. Survivorship Research (64)
  5. Epidemiology and Biostatistics (47)
  6. Biostatistics Service (45)

More Groups

People
  1. Clifford Hudis (61)
  2. Sujata Patil (40)
  3. Larry Norton (34)
  4. Patrick Morris (22)
  5. Maura Dickler (17)
  6. Stephen Solomon (17)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2018 (1)
  4. 2017 (2)
  5. 2016 (11)
  6. 2015 (10)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Cancer Research (14)
  3. Clinical Cancer Research (4)
  4. Cancer (3)
  5. Clinical Breast Cancer (3)
  6. Journal for ImmunoTherapy of Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (7)
  4. Springer (4)
  5. Wiley Blackwell (4)
  6. Biomed Central Ltd (3)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone scintigraphy (BS) may no longer be relevant in the era of integrated PET/CT for women undergoing evaluation for suspected metastatic breast cancer (MBC)
    Meeting Abstract

    Mcarthur, H. L.; Lynch, C.; Morris, P.; Larson, S.; Grabski, K.; Howard, J.; Patil, S.; Hudis, C. A.; Dickler, M. N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • High resolution representational oligonucleotide microarray analysis (ROMA) suggests that TOPO2 and HER2 co-amplification is uncommon in human breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C. A.; Hicks, J.; Norton, L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • TOPO2A and HER2 co-amplification is uncommon by high resolution representational oligonucleotide microarray analysis (ROMA) in human breast cancer
    Meeting Abstract

    Hicks, J.; Mcarthur, H.; Tan, L. K.; Patil, S.; Wigler, M.; Hudis, C.; Norton, L.
    Annals of Oncology (2009)

    Fulltext@MSK | Save
  • Therapeutic options for metastatic breast cancer
    Journal Article

    Morris, P. G.; Mcarthur, H. L.; Hudis, C. A.
    Expert Opinion on Pharmacotherapy (2009)

    Fulltext@MSK | Save
  • Aromatase inhibitor strategies in metastatic breast cancer
    Journal Article

    Mcarthur, H. L.; Morris, P. G.
    International Journal of Women's Health (2009)

    Fulltext@MSK | Save
  • An overview of HER-targeted therapy with lapatinib in breast cancer
    Journal Article

    Mcarthur, H.
    Advances in Therapy (2009)

    Fulltext@MSK | Save
  • Trastuzumab: A picky partner?
    Journal Article

    Mcarthur, H. L.; Hudis, C. A.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole
    Journal Article

    Kennecke, H. F.; Mcarthur, H. L.; Gelmon, K. A.; Olivotto, I. A.; Speers, C. H.; Ellard, S. L.; O'Reilly, S. E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Osteonecrosis of the jaw (ONJ) among intravenous (IV) bisphosphonate- and/or bevacizumab-treated patients (pts) at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    McArthur, H. L.; Estilo, C.; Huryn, J.; Williams, T.; Fornier, M.; Traina, T. A.; Howard, J.; Hudis, C. A.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Incidence and severity of sensory neuropathy (SN) with bevacizumab (B) added to dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound (nab) paclitaxel (P) in patients (pts) with early stage breast cancer (BC)
    Meeting Abstract

    Sierecki, M. R.; Rugo, H. S.; McArthur, H. L.; Traina, T. A.; Paulson, M.; Rourke, M.; Norton, L.; Seidman, A. D.; Hudis, C. A.; Dickler, M. N.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save